These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15350700)

  • 1. Adrenomedullin as a sensitive marker for coronary and peripheral arterial complications in patients with atherosclerotic risks.
    Suzuki Y; Horio T; Nonogi H; Hayashi T; Kitamura K; Eto T; Kangawa K; Kawano Y
    Peptides; 2004 Aug; 25(8):1321-6. PubMed ID: 15350700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma adrenomedullin concentration is increased in patients with peripheral arterial occlusive disease associated with vascular inflammation.
    Suzuki Y; Horio T; Hayashi T; Nonogi H; Kitamura K; Eto T; Kangawa K; Kawano Y
    Regul Pept; 2004 Apr; 118(1-2):99-104. PubMed ID: 14759562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM.
    García-Unzueta MT; Berrazueta JR; Pesquera C; Obaya S; Fernández MD; Sedano C; Amado JA
    J Diabetes Complications; 2005; 19(3):147-54. PubMed ID: 15866060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin.
    Nishida H; Horio T; Suzuki Y; Iwashima Y; Kamide K; Kangawa K; Kawano Y
    Peptides; 2008 Apr; 29(4):599-605. PubMed ID: 18222566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease.
    Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F
    Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adrenomedullin in cerebrovascular disease: a possible indicator of endothelial injury.
    Kuwasako K; Kida O; Kitamura K; Kato J; Eto T
    Int Angiol; 1997 Dec; 16(4):272-9. PubMed ID: 9543227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
    Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma adrenomedullin level and development of hypertension.
    Kato J; Kitamura K; Eto T
    J Hum Hypertens; 2006 Aug; 20(8):566-70. PubMed ID: 16625237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension.
    Shankar A; Li J; Nieto FJ; Klein BE; Klein R
    Am Heart J; 2007 Sep; 154(3):495-501. PubMed ID: 17719297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow.
    Li JJ; Qin XW; Li ZC; Zeng HS; Gao Z; Xu B; Zhang CY; Li J
    Clin Chim Acta; 2007 Oct; 385(1-2):43-7. PubMed ID: 17706955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
    Miller M; Zhan M; Havas S
    Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics.
    Vizza CD; Letizia C; Badagliacca R; Sciomer S; Poscia R; Della Rocca G; Iacoboni C; Leonardo de L; Quattrucci S; Dario C; Luigi P; Fedele F
    Regul Pept; 2006 Sep; 136(1-3):85-91. PubMed ID: 16815566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Underrecognized peripheral arterial disease in patients with acute coronary syndrome: prevalence of traditional and emergent cardiovascular risk factors].
    Huelmos A; Jiménez J; Guijarro C; Belinchón JC; Puras E; Sánchez C; Casas ML; López-Bescos L
    Rev Esp Cardiol; 2005 Dec; 58(12):1403-10. PubMed ID: 16371199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease.
    Vu JD; Vu JB; Pio JR; Malik S; Franklin SS; Chen RS; Wong ND
    Am J Cardiol; 2005 Sep; 96(5):655-8. PubMed ID: 16125489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies.
    Wilson AM; Kimura E; Harada RK; Nair N; Narasimhan B; Meng XY; Zhang F; Beck KR; Olin JW; Fung ET; Cooke JP
    Circulation; 2007 Sep; 116(12):1396-403. PubMed ID: 17724262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
    Linnemann B; Voigt W; Nobel W; Janka HU
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Circulation; 2005 Aug; 112(7):976-83. PubMed ID: 16087797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.